Title |
Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges
|
---|---|
Published in |
Current Cardiology Reports, June 2014
|
DOI | 10.1007/s11886-014-0501-8 |
Pubmed ID | |
Authors |
Mads J. Andersen, Barry A. Borlaug |
Abstract |
Heart failure (HF) is the leading cause of hospitalization among older adults and the prevalence is growing with the aging populations in western countries. Approximately one-half of patients with HF have preserved ejection fraction (HFpEF). In contrast to HF with reduced EF (HFrEF), there is no proven effective treatment for HFpEF. The pathophysiology of HFpEF is complex, and the dominant mechanisms leading to symptoms of HF often vary between afflicted patients, confounding efforts to apply "one-size fits all" types of therapeutic approaches. Current treatment strategies focus on control of volume status and comorbidities, but future research aimed at individualized therapies holds promise to improve outcomes in this increasingly prevalent form of cardiac failure. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 1% |
Unknown | 87 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 17 | 19% |
Student > Ph. D. Student | 15 | 17% |
Student > Master | 10 | 11% |
Researcher | 8 | 9% |
Student > Doctoral Student | 7 | 8% |
Other | 13 | 15% |
Unknown | 18 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 35% |
Agricultural and Biological Sciences | 8 | 9% |
Nursing and Health Professions | 6 | 7% |
Biochemistry, Genetics and Molecular Biology | 6 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 6 | 7% |
Unknown | 27 | 31% |